Literature DB >> 26490034

Effects of self-administered methamphetamine on discrimination learning and reversal in nonhuman primates.

Brian D Kangas, Jack Bergman.   

Abstract

RATIONALE: Frequent exposure to methamphetamine has been reported to adversely influence cognitive behavior and, in particular, inhibitory control processes.
OBJECTIVE: The present studies were conducted in squirrel monkeys to assess the effects of daily intravenous methamphetamine self-administration on touch screen-based repeated acquisition and discrimination reversal tasks thought to reflect behavioral dimensions of, respectively, learning and response inhibition.
METHODS: First, stable methamphetamine-maintained behavior was established in each subject (0.35-1.6 mg/kg/session), and subsequently, a second daily session of discrimination learning was conducted (20 h later). Subjects first learned to discriminate between two simultaneously presented stimuli (acquisition) and, subsequently, to re-learn the discrimination with the contingencies switched (reversal). The role of the interval between self-administration and touch screen sessions was evaluated, as well as the effects of abrupt methamphetamine discontinuation.
RESULTS: Results indicate that daily methamphetamine self-administration markedly disrupted the development of discrimination learning, initially requiring nearly twice the number of trials to master discriminations. The magnitude of adverse effects in individual subjects correlated to the level of daily methamphetamine intake. Importantly, however, behavioral disruption of discrimination learning was surmounted following remedial training. Once criterion levels of discrimination performance were achieved, subsequent development of reversal performance was largely unaffected except when the interval between self-administration and touch screen session was short and, thus, likely a result of methamphetamine’s direct effects. Discontinuation of methamphetamine produced no disruption in acquisition or reversal.
CONCLUSION: These results indicate that self-administered methamphetamine can markedly disrupt learning processes and highlight key differences in its effects on different aspects of discrimination learning.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26490034      PMCID: PMC4841750          DOI: 10.1007/s00213-015-4107-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  Effects of the cannabinoid CB(1) receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal.

Authors:  P M Beardsley; B R Martin
Journal:  Eur J Pharmacol       Date:  2000-01-03       Impact factor: 4.432

2.  Dysregulation of D₂-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure.

Authors:  Stephanie M Groman; Buyean Lee; Emanuele Seu; Alex S James; Karen Feiler; Mark A Mandelkern; Edythe D London; J David Jentsch
Journal:  J Neurosci       Date:  2012-04-25       Impact factor: 6.167

Review 3.  A review of the clinical pharmacology of methamphetamine.

Authors:  Christopher C Cruickshank; Kyle R Dyer
Journal:  Addiction       Date:  2009-04-29       Impact factor: 6.526

4.  Updated estimates of fatality reduction by curtain and side air bags in side impacts and preliminary analyses of rollover curtains.

Authors: 
Journal:  Ann Emerg Med       Date:  2015-02       Impact factor: 5.721

Review 5.  Reversal learning as a measure of impulsive and compulsive behavior in addictions.

Authors:  Alicia Izquierdo; J David Jentsch
Journal:  Psychopharmacology (Berl)       Date:  2011-11-29       Impact factor: 4.530

6.  Repeated acquisition and discrimination reversal in the squirrel monkey (Saimiri sciureus).

Authors:  Brian D Kangas; Jack Bergman
Journal:  Anim Cogn       Date:  2013-06-22       Impact factor: 3.084

7.  Methamphetamine-induced increases in putamen gray matter associate with inhibitory control.

Authors:  Stephanie M Groman; Angelica M Morales; Buyean Lee; Edythe D London; James David Jentsch
Journal:  Psychopharmacology (Berl)       Date:  2013-06-10       Impact factor: 4.530

Review 8.  Psychostimulants and cognition: a continuum of behavioral and cognitive activation.

Authors:  Suzanne Wood; Jennifer R Sage; Tristan Shuman; Stephan G Anagnostaras
Journal:  Pharmacol Rev       Date:  2013-12-16       Impact factor: 25.468

Review 9.  An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans.

Authors:  Andy C Dean; Stephanie M Groman; Angelica M Morales; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2012-09-05       Impact factor: 7.853

10.  A novel touch-sensitive apparatus for behavioral studies in unrestrained squirrel monkeys.

Authors:  Brian D Kangas; Jack Bergman
Journal:  J Neurosci Methods       Date:  2012-07-10       Impact factor: 2.390

View more
  4 in total

1.  Remifentanil maintains lower initial delayed nonmatching-to-sample accuracy compared to food pellets in male rhesus monkeys.

Authors:  Blake A Hutsell; Matthew L Banks
Journal:  Exp Clin Psychopharmacol       Date:  2017-12       Impact factor: 3.157

Review 2.  Touchscreen technology in the study of cognition-related behavior.

Authors:  Brian D Kangas; Jack Bergman
Journal:  Behav Pharmacol       Date:  2017-12       Impact factor: 2.293

3.  Discrimination learning in oxycodone-treated nonhuman primates.

Authors:  Sarah L Withey; Rachel J Doyle; Erica N Porter; Jack Bergman; Brian D Kangas
Journal:  Drug Alcohol Depend       Date:  2019-11-27       Impact factor: 4.492

4.  Effects of chronic cocaine self-administration and N-acetylcysteine on learning, cognitive flexibility, and reinstatement in nonhuman primates.

Authors:  Brian D Kangas; Rachel J Doyle; Stephen J Kohut; Jack Bergman; Marc J Kaufman
Journal:  Psychopharmacology (Berl)       Date:  2019-03-15       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.